Literature DB >> 8218603

Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia.

M A Geyer1, L S Wilkinson, T Humby, T W Robbins.   

Abstract

Schizophrenic patients exhibit deficits in the prepulse inhibition of startle, an operational measure of the sensorimotor gating deficits that are theorized to contribute to cognitive disorganization. In rats, the activation of mesolimbic dopamine (DA) disrupts prepulse inhibition, providing a useful model of the similar deficits in sensorimotor gating in schizophrenic patients. Rats reared in isolation exhibit neurochemical and behavioral abnormalities suggestive of hyperactivity in mesolimbic DA systems. In the present studies, rats reared in social groups or in isolation were tested in startle response paradigms using 120 or 105 dB acoustic pulses, some of which were preceded (100 msec) by prepulses that were 2, 4, 8, or 16 dB above the 65 dB background. Isolation-reared animals were hyperreactive only in response to the initial few startle stimuli. The amount of prepulse inhibition was decreased significantly in isolation-reared animals, particularly when midrange 8 dB prepulses were used. A subsequent study replicated the effect of isolation rearing on prepulse inhibition and suggested that the deficit in sensorimotor gating exhibited by isolation-reared animals may be normalized by the administration of the DA antagonist raclopride (0.05 mg/kg). Hence, isolation rearing provides a nonpharmacological way to induce in rats a deficit in sensorimotor gating that is exhibited by schizophrenic patients.

Entities:  

Mesh:

Year:  1993        PMID: 8218603     DOI: 10.1016/0006-3223(93)90180-l

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  86 in total

Review 1.  Environmental influences on neural plasticity, the limbic system, emotional development and attachment: a review.

Authors:  R Joseph
Journal:  Child Psychiatry Hum Dev       Date:  1999

2.  Developmental markers of psychiatric disorders as identified by sensorimotor gating.

Authors:  Susan B. Powell; Mark A. Geyer
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 3.  Have studies of the developmental regulation of behavioral phenotypes revealed the mechanisms of gene-environment interactions?

Authors:  F Scott Hall; Maria T G Perona
Journal:  Physiol Behav       Date:  2012-05-27

Review 4.  Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.

Authors:  Christina Wilson; Alvin V Terry
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

Review 5.  Dynamic causal modeling for EEG and MEG.

Authors:  Stefan J Kiebel; Marta I Garrido; Rosalyn Moran; Chun-Chuan Chen; Karl J Friston
Journal:  Hum Brain Mapp       Date:  2009-06       Impact factor: 5.038

6.  Animal models of gene-environment interactions in schizophrenia.

Authors:  Yavuz Ayhan; Akira Sawa; Christopher A Ross; Mikhail V Pletnikov
Journal:  Behav Brain Res       Date:  2009-04-18       Impact factor: 3.332

7.  Baseline prepulse inhibition of the startle reflex predicts the sensitivity to the conditioned rewarding effects of cocaine in male and female mice.

Authors:  M C Arenas; C I Navarro-Francés; S Montagud-Romero; J Miñarro; C Manzanedo
Journal:  Psychopharmacology (Berl)       Date:  2018-06-29       Impact factor: 4.530

8.  The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia.

Authors:  Amanda Crider; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2016-04-16

9.  Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency.

Authors:  Irina Fedorova; Anita R Alvheim; Nahed Hussein; Norman Salem
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

Review 10.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.